Similarly, with a prior probability of 0.25, the homozygote model of H19 rs3024270 polymorphism was associated with cancer risk and the recessive model of H19 rs3024270 polymorphis was associated with cancer risk (P < 0.2). This evidence concerns the gene H19 and cancer.